GyroStim for Concussion

This trial tests a new therapy called SMART, which uses a device called the GyroStim to treat post-concussion syndrome (PCS). Researchers aim to determine if adding SMART therapy to regular physical and speech therapy can speed recovery and improve outcomes compared to regular therapy alone. The trial seeks adults who have experienced a concussion with ongoing symptoms such as dizziness or balance issues for at least four weeks. Participants will be divided into groups to compare regular therapy with therapy that includes SMART sessions. As an unphased trial, this study offers participants the chance to contribute to pioneering research that could enhance recovery options for PCS.

The trial does not specify if you need to stop taking your current medications. However, if you are on prescription anticoagulant medications like warfarin, you cannot participate. Over-the-counter aspirin is allowed.

Research has shown that the GyroStim device, used in SMART therapy, is safe for people. The FDA has cleared the device, confirming its safety for treating conditions like concussions. Clinics have used it since 2010, demonstrating that it is generally well-tolerated. Studies have not identified any major safety issues with its use. As a non-invasive treatment, the GyroStim does not involve surgery or entering the body, which reduces the risk of side effects. Overall, evidence suggests that GyroStim is a safe option for treating post-concussion symptoms.¹²³⁴⁵

Researchers are excited about using the GyroStim device for concussion treatment because it introduces a dynamic form of therapy known as SMART (Sensory, Motor, and Adaptive Rehabilitation Technology). Unlike traditional treatments that primarily rely on physical and speech/cognitive rehabilitation therapy, GyroStim involves a rotating chair that stimulates the vestibular system, potentially accelerating recovery. This novel approach could enhance rehabilitation outcomes by targeting the brain's ability to adapt and reorganize, offering a promising new direction for concussion therapy.

Research has shown that the GyroStim device, used in a therapy called SMART, can accelerate recovery from post-concussion syndrome. In this trial, participants will receive different treatment combinations. Some will undergo standard care, including physical therapy and speech therapy/cognitive rehabilitation therapy. Others will receive these standard therapies plus SMART sessions with the GyroStim device at varying frequencies. Studies have found that patients using GyroStim recover up to eight times faster than those relying solely on traditional therapies. More frequent use of GyroStim results in even quicker recovery. Clinical evidence suggests that incorporating GyroStim into treatment plans significantly speeds up recovery and reduces symptoms. These findings make it a promising option for those facing post-concussion challenges.¹²⁵⁶⁷